Summary
Proteomics has rapidly become an important tool for life science research, allowing the integrated analysis of global protein expression from a single experiment. To accommodate the complexity and dynamic nature of any proteome, researchers must use a combination of disparate protein biochemistry techniques, often a highly involved and time-consuming process. Whilst highly sophisticated individual technologies for each step in studying a proteome are available, true high-throughput proteomics that provides a high degree of reproducibility and sensitivity has been difficult to achieve. The development of high throughput proteomic platforms, encompassing all aspects of proteome analysis and integrated with genomics and bioinformatics technology, therefore represents a crucial step for the advancement of proteomics research. ProteomIQ TM (Proteome Systems, Sydney, Australia) is the first fully integrated, start-to-finish proteomics platform to enter the market. Sample preparation and tracking, centralized data acquisition and instrument control, and direct interfacing with genomics and bioinformatics databases are combined into a single suite of integrated hardware and software tools, facilitating high reproducibility and rapid turnaround times. This review will highlight some features of ProteomIQ, with particular emphasis on the analysis of proteins separated by two-dimensional polyacrylamide gel electrophoresis.
Introduction
In the wake of large scale genome sequencing projects, life science research has experienced a paradigm shift from the reductionist, single-protein biochemical approach to a more global view in the analysis of biological systems. Accordingly the field of proteomics, the study of the entire protein complement expressed by the genome [1], has experienced explosive growth and has become a revolutionary tool with promising applications across the biological sciences. Proteomics involves the systematic study of the identity, distribution, abundance and modifications of large sets of proteins from biological samples such as cells, tissues or fluids. Proteins are typically extracted, separated and analyzed using a diverse array of protein biochemistry technologies. By comparing the proteome of samples derived from normal and disease states or from differing metabolic conditions, for example, phenotypic or functional changes can be correlated with their underlying biochemical or pathological events. A major advantage of this global approach is that many changes can be considered in an integrated manner from a single experiment. Not surprisingly, there has been intense interest in the application of proteomics to foster better understanding of disease, identify new biomarkers to improve diagnosis, detection and prognosis, and to accelerate the development of new and existing therapeutics [2] [3] [4] [5] .
The proteome of any organism is highly variable and dynamic in nature, since protein expression and modification respond to both internal and external stimuli and are dependent on cell type, growth conditions, environmental influences or disease status.
The analysis of an individual's proteome therefore generates large amounts of information, leading to the requirement for a highly coordinated approach to data through an information management and analysis system, and was the first fully integrated proteomics platform to enter the market [6] . Since two-dimensional polyacrylamide gel electrophoresis (2DE) remains the most commonly used technology for proteomics, we will focus on the use of ProteomIQ in the generation of proteomic data from 2DE arrays.
Dealing with the diversity of the proteome
The highly variable and dynamic nature of protein expression and modification presents a number of unique challenges to the proteomics researcher, since any particular organism will have many permutations of its proteome dependent on cell type, growth conditions, environmental influences or disease status-all of which may influence the protein expression profile of a cell at any particular time. Whilst knowledge of the complete genomic content of humans and a number of pathogenic and biologically relevant organisms has become part of an indispensable platform for mining proteomic data, the DNA expression profile of a static genome does not reflect the additional dynamics of transcriptional and translational controls, and post-translational 6 modifications of proteins. For example, sequencing of the human genome has revealed between 20000 to 25000 protein-coding genes [7, 8] , not significantly different to the 25498 protein-coding genes found in organisms such as Arabidopsis thaliana [9] . The additional complexity of the proteome can arise through splice and translation isoforms, and post-translational processing and modifications such as glycosylation, phosphorylation or acetylation [10] [11] [12] [13] -in some cases, up to 1000 potential species of a single protein, based on transcriptional isoforms, have been described [14] . Taking such modifications into account, the estimated total number of protein species will therefore be orders of magnitude higher than the number of genes observed in any individual genome [15] .The occurrence and significance of such modifications, induced by intra-or extracellular stimuli or environmental responses, all contribute to the biological role of proteins in vivo and can neither be predicted nor understood from the genome. Proteins also display a wide dynamic range of expression levels; for example, 5-6 orders of magnitude in yeast [16] , and by at least 12 orders of magnitude in human blood serum [17, 18] . Every sample therefore has the potential to produce large numbers of complex proteomic permutations, characteristic of specific cell types, growth conditions or disease states.
To accommodate the complexity of the expressed proteome, a typical 2DE
proteomics workflow encompasses a number of sequential steps (fig 1) . The first of these involves the isolation of proteins from a sample using a suitable cocktail of detergents and denaturants. This must be done under conditions which are amenable to subsequent manipulations in the proteomics process. In even the simplest proteome, proteins often differ in abundance, size, pI and solubility, and thus sample fractionation prior to further analysis is often undertaken at this point to reduce sample complexity. or peptide fragmentation fingerprinting (PFF).
Sample preparation and pre-fractionation
Of primary importance in any proteomic investigation is the preparation of samples in an appropriate format for presentation to 2DE. The protein composition of any sample can be extremely varied-relative protein abundances, charge, size, pI or solubility, for example-and successful preparation requires an intimate knowledge of the sample and a clearly defined strategy to target proteins of interest. Typically, a sample is collected and often subjected to an "enrichment" stage prior to protein isolation-for example, the sub-cellular isolation of organelles or plasma membranes, or membrane stripping protocols designed to remove peripheral proteins [19] . Care must be taken to ensure consistency during the collection and enrichment phase, prior to entering the proteomics factory, as elements such as sample collection methods or storage may affect the quality and protein composition of the sample [20] . Proteins are then solubilized, denatured, reduced and alkylated in an appropriate cocktail of nonionic or zwitterionic surfactants, chaotropes and salts that are compatible with first dimension isoelectric focusing (IEF) [21] . The composition of the cocktail depends on the proteins being targeted-for example, membrane or cytoplasmic proteins-and no one solution is ideal for all samples [21] . Standardized methodologies for particular sample types are, therefore, (table 1) include extraction kits for the preparation of general or membrane proteins, and also for the depletion of albumin from serum and plasma.
Pre-fractionation prior to IEF is an important part of sample preparation, reducing sample complexity and increasing the protein load which may be separated on narrow-pH gradient gels by IEF [22] . This theoretically allows increased resolution, enrichment of low abundance proteins, specific targeting of proteins with particular pI values or 8 elimination of proteins from a sample (e.g. serum albumin, which accounts for ~60% of protein present in human plasma) and also allows tailoring of isoelectric fractions to specifically match narrow range IEF strips [23] . A number of preparative prefractionation devices, their uses and limitations have been recently reviewed [23, 24] .
ProteomIQ includes a multi-compartment electrolyzer (MCE) which fractionates proteins according to their isoelectric points (fig 2a) . A series of liquid-filled chambers are separated by semi-permeable membranes, each of which carries an immobilon-containing gel of a particular pH value [22] . When a potential difference is applied across the MCE, a discontinuous pI gradient is established where the pI of each membrane delimits the pI range of proteins focusing between them-in effect, a series of isoelectric "traps".
Generally, three fractions are produced (alkaline, neutral and acidic) although any combination of membranes may be used. This allows targeting of particular subproteomic fractions such as alkaline proteins, which are often under-represented in proteomic analyses, and the efficacy of isoelectric prefractionation in 2DE studies has been demonstrated for proteins from Escherichia coli and human plasma [22] , and also for low abundance and membrane proteins from the yeast Saccharomyces cerevisiae [25] . 
Protein Separation and Image Analysis
The most commonly used technique for protein separation remains 2DE, probably because of its economy, accessibility to most laboratories and a wealth of previous experience to draw upon [5] . In the first dimension, proteins are focused in an IPG strip.
Commercially available pre-cast IPG's are highly reliable and offer a wide range of broad 9 or narrow pH gradients. Several companies market pre-cast IPG's and focusing hardware. and also offers preparative pre-fractionation via MCE.
Following IEF the proteins are separated in the second dimension by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Second dimension polyacrylamide gels, when combined with first dimension IEF, still offer a number of advantages over non-gel systems in that they are able to separate, to homogeneity, hundreds or even thousands of proteins in a single step, can resolve intact protein isoforms, and are not overtly biased against any particular type of proteins (although, specialized gels and buffer systems might be required to deal with particular classes of proteins-e.g. acidic, basic, or hydrophobic proteins) [5, 28] . Resolution can also be varied according to the size of the gel, and so-called "zoom" gels, where IEF is performed in narrow pH range IPG's, may be used to achieve higher proteins loads in discrete pH ranges [5] . The major requirement for this step is that the polyacrylamide gels are prepared with a high level of consistency. [30, 31] .
Protein digestion and peptide analysis
Spot cutting, washing and digestion of protein spots from gels can be demanding, and are often a major bottleneck in proteomic investigations. Using robotic platforms for spot excision from gels and subsequent liquid delivery steps minimizes handling and avoids contamination or the introduction of inconsistencies. Typically, these platforms 11 consist of an image capture platform linked to spot cutting and liquid delivery systems.
The major requirement here is for precise spot cutting to minimize contamination, along with complete automation and rapid turnaround times to facilitate high throughput. [32] , and the ChIP promises to become an extremely important adjunct to current proteomics applications.
Protein Identification, Informatics and Validation
The final step in the 2DE proteomic workflow is the identification of protein spots by MS analysis. Whilst a number of different types of MS procedures are now available [34, 35] , MALDI-TOF and ESI-TOF remain the two most commonly employed.
MALDI-TOF is particularly well suited to proteomic analyses, as it is easily automatable and so is amenable to high throughput. It also has the advantages of high sensitivity and excellent resolution, and therefore is most commonly employed in high throughput proteomic analyses for protein identification [12] . The combination of MALDI-TOF and 2DE also offers some advantages over non-gel based proteomics approaches. Typically, LC-MS systems separate peptides in complex mixtures, providing identification of many more proteins than is possible from a 2DE system. However, identification is typically based on only one or a few peptides, and the intact protein is never observed [28] . This prevents additional protein coverage and makes identification of protein isoforms difficult [28] . The combination of MALDI-TOF and 2DE allows identification of tryptic peptides derived from the entire isolated protein, typically providing good coverage.
Since the intact protein is the starting material it is possible to examine individual modifications on peptides, providing information on the biological function and status of the protein [28] . and tandem mass spectrometry (MS/MS), and includes all bridging software and algorithms necessary for peptides and protein identification. Monoisotopic mass spectra peaks are harvested automatically using the Peak Harvester tool, which first processes spectra and then applies Poisson modeling to determine which peak in an isotopically resolved group represents the monoisotopic peptide mass [36] . Following peak harvesting, reliable protein identification can depend on several factors including the quality of MS data produced, the number of masses or mass distribution of masses submitted for query-the key problem in identification remains that peptide masses are generally not unique, and random matching of a peptide to a database sequence may produce a false positive [37] . In ProteomIQ, the harvested peptide masses are submitted to the IonIQ search engine, which uses a modified MOWSE scoring system [38] to assign a measure of probability to protein identifications, for PMF. Queries are submitted to SWISS PROT, TrEMBL (Swiss-Prot, TrEMBL, and PIR database information is now contained in UniProt; http://www.ebi.uniprot.org) or proprietary databases, and potential protein identifications and probability scores are returned along with links to the annotated gel(s) and integrated MS data viewers. Where peptide identification is ambiguous, further peptide fragmentation by PSD or MS/MS may be undertaken and ProteomIQ also includes search engines for analysis of these data types. Comparisons between several different scoring algorithms, including MS-FIT and MASCOT (which use a MOWSE scoring system), ProFound and SEQUEST have been recently reviewed [37] . A significant improvement in the pipeline would be the integration of several search engines to be used simultaneously for automated protein identification from MS data; thus far, algorithms implementing this kind of search are unavailable.
Protein identification by MS analysis ultimately requires experimental validation, especially where proteins match the database records for "hypothetical proteins" or "putative function". The nature of the validation process depends greatly on the kind of study undertaken, and the transition from putative protein identifications to specific biological or functional analyses is a limitation for many studies. The LIMS component of BioinformatIQ accommodates a number of sample preparation, electrophoretic or other handling procedures and allows uploading and association of third party data with any particular experiment. In this way, all subsequent validation information for the study may be stored in the central database.
Data Management, Integration and Quality Control
The major challenge facing proteomics resides in integration of the complex processes and management of the diverse data types generated during analysis of a The generation of large amounts of data requires careful quality control, and the issues of technical and biological variation in quantitative protein expression profiling were recently assessed [39] . Many sources of variation in quantitative 2DE analyses are possible-for example, biological variation in protein levels between experiments, error introduced during sample preparation, protein staining/labeling or gel running, or quantitation errors during image analysis and background subtraction [40] . Information capture is therefore of paramount importance to address the statistical aspects of variance in an experiment [40] . In the ProteomIQ platform, information concerning all aspects of the 2DE process-from sample preparation, through 2DE separation conditions and ultimately to MS analysis-is captured and stored in the LIMS. Integrated platforms such as ProteomIQ, ProteinScape or Ettan LWS also limit procedural inconsistencies by minimizing user intervention. Whilst no instrument is faultless, centralized data acquisition, storage and automated analyses facilitated by the software package controlling the platform all contribute to maintaining the quality of data output.
Non-gel based proteomics
Whilst this review is focused on the generation of 2DE arrays, each of the BioRad, Amersham Biosciences and Proteome Systems platforms also includes an automated LC-MS/MS platform for the separation and resolution of peptides in complex mixtures. This is useful for large-scale analyses of proteins present in the proteome, which exist in at least one form at any particular time. Automated LC-MS systems have been widely used in "shotgun" approaches to proteomics (for review, see [12] ), generally presenting peptides for ESI-MS/MS analysis. ProteomIQ uses a LCQ™ Deca XP Plus
[116] with an on-board LC system, and is integrated with ProteomIQ via BioinformatIQ.
The use of LC-MS/MS can enhance the ability to resolve protein modifications, or provide additional protein coverage and thus more accurate protein identification and analysis of post-translational modifications. Non-gel based proteomics therefore forms an important complement to any high-throughput 2DE platform.
Conclusion
Proteomics has emerged as a powerful tool for the global analysis of biological systems, and has clear potential for accelerating the discovery and development of new diagnostic and therapeutic molecules [2] [3] [4] [5] . ProteomIQ is the first high-throughput, purpose-designed proteomics platform that successfully integrates existing and emerging proteomics technologies. Several studies have already demonstrated the versatility and efficacy of ProteomIQ for integrated proteomic analyses. These include the identification of low abundance and membrane proteins from the yeast S. cerevisiae [25] , identification of novel biomarkers from sputum and serum samples of patients suffering from cystic fibrosis or tuberculosis, and the identification of protein glycosylation modifications on mucins isolated from the sputum of CF patients, which have potential as novel diagnostic or therapeutic molecules [41] . The application of multiple chemistries to single protein spots using the ChIP has also been established, and has enormous potential for highthroughput proteomics and development of new diagnostic approaches [32] . The authors are currently using ProteomIQ in a proteomic analysis of the cell cycle in bacteria, aimed at identification of novel antibiotic targets and new therapeutic agents.
The development of high throughput platforms that are purpose-designed the ProteomeWorks™ System [6] . These platforms offer high-throughput screening integrated with the genomics and bioinformatics capabilities necessary for identification of biomarkers, drug targets and drug leads. Large lists of proteomic profiles for cataloguing are of limited value, and more targeted experimental approaches merging systems biology and hypothesis-driven research will become routine. The ability to perform iterative, efficient systematic profiling of differentially perturbed systems is vital for advancing proteomics research.
Expert Opinion and Five Year View
Several key areas are expected to develop proteomics research further in the immediate future. These include improved detection systems for 2DE based proteomics, increased use of non-gel based proteomics, and further developments in informatics for handling and analyzing the huge datasets generated by proteomics researchers.
2DE remains the most commonly employed technique for proteomics, but as yet it has proven to be limited particularly for the display of low abundance and membrane proteins [42, 43] . These classes of proteins require specialized protocols and preparation [29] ). For example, multi-labeling techniques can significantly reduce the time taken for image analysis of 2DE arrays, and also reduce the number of gels which must be produced. Affinity purification using anti-phosphoprotein antibodies and immobilized metal ion affinity chromatography has been used extensively for phosphoprotein enrichment (reviewed in [24] ). New strategies for the chemical derivitisation of phosphate groups on serine or threonine residues to incorporate a thiol group [44] or biotin tag [45] as an affinity handle have also been reported, as has a new fluorescent reagent (Pro-Q Diamond phosphoprotein dye [104]) specific for 20 phosphoproteins and suitable for their detection after separation by 2DE [46, 47] .
Enhanced detection of proteins using existing instrumentation would be an enormous asset to researchers, enabling deeper proteomic analyses without the cost associated with the purchase of more sensitive equipment. Quantitative protein detection, whether via labeling technology or quantitative MS techniques, could eliminate the need for a reference gel and represents a major potential advancement for future proteomics research.
Apart from new labeling technologies, increased sensitivity of MS instrumentation will also be important in providing a greater depth of proteome characterization. Accelerator MS, where atoms are accelerated through a high voltage field to strip away outer valency electrons and the resulting positive species analyzed [48] , can provide protein sequence information at the attomole level [35] and would potentially be extremely useful for low abundance proteins. Of course, complementary sensitivity in detection and a capacity to process low abundance proteins without high losses will be essential for increased MS sensitivity to be effectively employed. In addition, current MS techniques are still not adequate for the analysis of complex posttranslational modifications, although much progress has been made [35] .
Non-gel systems are gaining popularity and show great promise in the separation and global analysis of proteins [12, 20] . Techniques such as multi-dimensional protein identification technology (MudPIT), where peptides are separated based on their charge and hydrophobicity prior to submission for ESI-MS/MS, theoretically allows large numbers of proteins to be identified [3] . Isotope-coded affinity tagging (ICAT) [49] allows quantitative expression profiling in an LC-MS/MS system by using isotopically coded tags to specifically label proteins. A number of other labeling chemistries have also been explored (reviewed in [12] ). Whilst LC-MS/MS remains slow compared to MALDI-TOF MS [50] it is easily automated and recent work has demonstrated the comprehensive analysis of both soluble and membrane proteins [51, 52] . Non-gel proteomic systems will therefore provide an important complement to 2DE in the future. [55, 56] . This software has already been employed in the proteomic identification of glycoprotein targets with a view to developing new therapeutics to combat lung disease in patients suffering from cystic fibrosis [41] . Glycosuite has also been used to examine glycan structures present on human plasma glycoproteins [32, 57] . The ability to analyze glycosylation modifications on proteins provides a powerful addition to the integrated package of proteomics research tools.
Systems biology relies on the quality of the databases it exploits, and informatics packages such as BioinformatIQ, designed to handle large and diverse datasets and directly integrate them with genomics and bioinformatics databases, are a major step in the right direction. Currently, our ability to collect data far outweighs our ability to analyze it in a meaningful way. To provide further insights into the functional organization of complex biological systems, integration of centralized proteomics databases with validation data, activity profiles, interaction maps and protein modifications will become standard. It has been proposed that a score might be assigned
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to proteins in such a database, as a measure of confidence for any protein interactions observed [12] . Of course, the complexity and context-dependent nature of each component in a biological network make this a daunting task which will be some time
away. An interesting proposition is the development of modeling algorithms for the integration of such information [58] . These might be used to predict interacting components of pathways, which may not be expected by typical biochemical techniques or knowledge-based approaches. Such an integrated genomics and proteomics approach has been applied to the galactose metabolic network in yeast [59] . By assimilating data using similar algorithms, it should become possible to produce computational models for individual organisms, where cellular behaviors are predicted prior to being experimentally tested.
Key Issues
• proteomics research generates very large and diverse datasets, which require a coordinated approach to data collection and analysis
• high throughput proteomics requires integration for storing, manipulating and mining large amounts of data, and automation for consistent sample handling on a large scale
• the application of new, integrated start-to-finish automated proteomics platforms such as ProteomIQ simplifies proteomic analyses and facilitates rapid and efficient data collection, analysis and archiving
• increased detection sensitivity, new adjuncts to 2DE technology and more integrated informatics approaches will continue to drive proteomics research and aid in the identification of new biomarkers for diagnostic and therapeutic applications were fractionated using an MCE device and the pH 6.5-11 fraction arrayed by 2DE. First dimension focusing was in precast IPG strips covering the pH 3-10 range, and second dimension SDS-PAGE was in 6-15% gradient GelChips TM . Proteins were visualized by staining with silver. 
